BioNTech SE announced that the Supervisory Board has appointed James Ryan, Ph.D., to the Management Board as Chief Legal Officer (CLO), effective September 1, 2023. As part of the Management Board, James Ryan will continue to lead the Company?s corporate legal strategy and global legal operations including transactions, corporate governance, securities, intellectual property (IP), insurance, data privacy, among others. Prior to his appointment to the Management Board, James Ryan served as the Company?s General Counsel and Senior Vice President Legal & IP.

James Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry. He joined BioNTech in July 2018. Since then, he has guided the Company through a wide range of key business, IP and transactional activities, equity capital markets transactions including the Company?s IPO in 2019, mergers and acquisitions, and strategic collaborations.

He and his teams played a pivotal role in the successful development of the Pfizer-BioNTech COVID-19 Vaccine, supporting every aspect of the program, its launch and commercialization. James Ryan has a Ph.D. in epigenetics from the University of St Andrews, is a member of the Law Society of England & Wales and is a member of the Law Society of Ireland.